John Tegeler

Mr. Tegeler was a pharmaceutical executive with more than 10 years of experience at the global vice president level including strategic leadership for up to 500 R & D associates in 5 countries and management responsibility for an annual budget of up to $120M. As a global R&D management board member he contributed to long range planning and capital management for a division of 1,300 associates worldwide and was liaison with the global Patent department for strategic purposes. His career spanned 34 years at Sanofi US and 5 predecessor companies in Bridgewater.

Mr. Tegeler holds a BS in Chemistry at SUNY Albany, a PhD in Organic Chemistry at SUNY Buffalo, and an NIH Postdoctoral Fellow at Stanford University.

Mr. Tegeler has been an active contributor to the local community. He led one of the United Way campaigns at Hoechst Celanese raising over $250K. He also served on the National Disautonomia Research Foundation Board, a patient advocacy group. He was appointed Trustee at Immaculate Conception parish for annual budget review for submission to the diocese office in Metuchen. Additionally, Mr. Tegeler participates in Family Support Coalition of NJ and Family Support Council of Somerset & Union Counties. He also participates in activities by PLAN NJ, Our House Foundation and Cherished Creations.

Mr. Tegeler’s son, graduated from The Midland School and currently attends the Midland Adult Services Employment Program. Mr. Tegeler and his wife served on the Midland Parent Association Board. Mr. Tegeler joined The Midland Corporation Board of Trustees in 2015. He currently serves on the Strategic Planning and Personnel Committee and Facility / Technology Committee.